Frontiers in Cardiovascular Drug Discovery Volume 4
4.4 (45 items)
Limited Time Sale$61.04 cheaper than the new price!!
Free cash-on-delivery fees for purchases over $99
Product details
| Management number | 231809366 | Release Date | 2026/06/18 | List Price | $40.70 | Model Number | 231809366 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Frontiers in Cardiovascular Drug Discovery is a book series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The book series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology. The fourth volume of the series covers the following topics: -Aspirin administration-Adenosine receptor targeting for cardiovascular therapy-Drug treatment of patients with coronary stenting-Immunosuppressive drugs in heart transplantation-PCSK9 inhibition for lowering LDL-C levels. Read more
| ISBN10 | 1681084007 |
|---|---|
| ISBN13 | 978-1681084008 |
| Language | English |
| Publisher | Bentham Science Publishers |
| Dimensions | 7 x 0.48 x 10 inches |
| Item Weight | 1.11 pounds |
| Print length | 204 pages |
| Publication date | April 5, 2019 |
Cardiovascular
Radio Frequency Filters
Correction of product information
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form